Kucinski A

References (8)

Title : Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071 - Kucinski_2020_Psychopharmacology.(Berl)_237_137
Author(s) : Kucinski A , Phillips KB , Koshy Cherian A , Sarter M
Ref : Psychopharmacology (Berl) , 237 :137 , 2020
PubMedID: 31620809

Title : Repetitive mild concussion in subjects with a vulnerable cholinergic system: Lasting cholinergic-attentional impairments in CHT+\/- mice - Koshy_2019_Behav.Neurosci_133_448
Author(s) : Koshy Cherian A , Tronson NC , Parikh V , Kucinski A , Blakely RD , Sarter M
Ref : Behavioral Neuroscience , 133 :448 , 2019
PubMedID: 30896190

Title : Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease - Koshy_2019_Psychopharmacology.(Berl)_236_1701
Author(s) : Koshy Cherian A , Kucinski A , Wu R , de Jong IEM , Sarter M
Ref : Psychopharmacology (Berl) , 236 :1701 , 2019
PubMedID: 30607479

Title : Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements - Kucinski_2017_Eur.J.Neurosci_45_217
Author(s) : Kucinski A , de Jong IE , Sarter M
Ref : European Journal of Neuroscience , 45 :217 , 2017
PubMedID: 27469080

Title : Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease - Kucinski_2013_Pharmacol.Biochem.Behav_111_1
Author(s) : Kucinski A , Wersinger S , Stachowiak EK , Corso TD , Parry MJ , Zhang J , Jordan K , Letchworth SR , Bencherif M , Stachowiak MK
Ref : Pharmacol Biochem Behav , 111 :1 , 2013
PubMedID: 23872135

Title : Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model - Stachowiak_2013_Schizophr.Res_143_367
Author(s) : Stachowiak MK , Kucinski A , Curl R , Syposs C , Yang Y , Narla S , Terranova C , Prokop D , Klejbor I , Bencherif M , Birkaya B , Corso T , Parikh A , Tzanakakis ES , Wersinger S , Stachowiak EK
Ref : Schizophr Res , 143 :367 , 2013
PubMedID: 23231877

Title : alpha7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia - Kucinski_2012_Schizophr.Res_136_82
Author(s) : Kucinski A , Syposs C , Wersinger S , Bencherif M , Stachowiak MK , Stachowiak EK
Ref : Schizophr Res , 136 :82 , 2012
PubMedID: 22285656

Title : TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia - Hauser_2009_Biochem.Pharmacol_78(7)_803
Author(s) : Hauser TA , Kucinski A , Jordan KG , Gatto GJ , Wersinger SR , Hesse RA , Stachowiak EK , Stachowiak MK , Papke RL , Lippiello PM , Bencherif M
Ref : Biochemical Pharmacology , 78 :803 , 2009
PubMedID: 19482012